RI-AG03 acetate is the acetate form of RI-AG03. RI-AG03 is an orally active peptide inhibitor that can cross the blood-brain barrier to inhibit Tau aggregation. It effectively prevents Tau aggregation in both in vivo and in vitro models and improves associated neurodegenerative and behavioral phenotypes. RI-AG03 is useful for researching tauopathies such as Alzheimers disease.
Target-Kategorie:
Microtubule Associated
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
